See also this year's filing and all EDGAR filings for this company.
PDF Report 0001445815_2021_Bioxytran_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
| warning | Excluding company: variable exceeds outlier threshold | pre-agg | {'variable': 'Expenses', 'value': 4214434, 'size_variable': 'Assets', 'size_value': 119290, 'ratio': 35.3, 'threshold': 20} |
Graph
Absolute values for 0001445815, Bioxytran INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 316,403 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 10,000 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 0 |
| 4 | LiabilitiesCurrent | 2,267,659 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 478,308 |
| 9 | ResearchAndDevelopmentExpense | 544,519 |
| 10 | remainder_Expenses | 319,300 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | -3,832,765 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 326,403 |
| 1 | Liabilities | 2,267,659 |
| 2 | Expenses | 1,342,127 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | -1,941,256 |
| 5 | NetIncome | -5,174,892 |
| 6 | ComprehensiveNetIncome | -5,174,892 |
| 7 | BaseVar | 3,884,477 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -7.25 |
| 9 | EconomicCapitalRatio | 0.0210 |
Edgar->Model Mapping
Feature Distribution
Change over Time
